UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

The New England journal of medicine, 2004-07, Vol.351 (5), p.438-450

2004

Volltextzugriff (PDF)

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement

Medical journal of Australia, 2019-06, Vol.210 (10), p.462-468

2019

Volltextzugriff (PDF)

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy

Addiction (Abingdon, England), 2011-05, Vol.106 (5), p.977-984

2011

Volltextzugriff (PDF)

Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency

Frontiers in immunology, 2022-02, Vol.13, p.815193

2022

Volltextzugriff (PDF)

Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men

BMC infectious diseases, 2017-03, Vol.17 (1), p.185-185, Article 185

2017

Volltextzugriff (PDF)

Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men

Medical journal of Australia, 2013-03, Vol.198 (4), p.210-214

2013

Volltextzugriff (PDF)

Guarding the sleeping giant: hepatitis B screening and management in patients with hematological malignancy

Leukemia & lymphoma, 2014-11, Vol.55 (11), p.2426-2427

2014

Volltextzugriff (PDF)

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

Trials, 2020-10, Vol.21 (1), p.847-3, Article 847

2020

Volltextzugriff (PDF)

Current treatment of HIV/hepatitis B virus coinfection

Journal of gastroenterology and hepatology, 2008-05, Vol.23 (5), p.699-706

2008

Volltextzugriff (PDF)

Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy

Journal of Virology, 2005-03, Vol.79 (5), p.3038-3051

2005

Volltextzugriff (PDF)

Non-cirrhotic portal hypertension in HIV mono-infected patients

Journal of gastroenterology and hepatology, 2012-09, Vol.27 (9), p.1512-1519

2012

Volltextzugriff (PDF)

Why do we not yet have combination chemotherapy for chronic hepatitis B?

Medical journal of Australia, 2007-02, Vol.186 (4), p.204-206

2007

Volltextzugriff (PDF)

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline?

Current opinion in pulmonary medicine, 2004-05, Vol.10 (3), p.197-203

2004

Volltextzugriff (PDF)

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Clinical infectious diseases, 2018-09, Vol.67 (7), p.1010-1017

2018

Volltextzugriff (PDF)

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

American journal of transplantation, 2015-03, Vol.15 (3), p.827-832

2015

Volltextzugriff (PDF)

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

The Lancet (British edition), 2015-03, Vol.385 (9973), p.1098-1106

2015

Volltextzugriff (PDF)

Management of healthcare workers after occupational exposure to hepatitis C virus

Medical journal of Australia, 2003-08, Vol.179 (3), p.153-157

2003

Volltextzugriff (PDF)

An audit of obstetricians’ management of women potentially infected with blood‐borne viruses

Medical journal of Australia, 2004-04, Vol.180 (7), p.328-332

2004

Volltextzugriff (PDF)

Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era

Journal of telemedicine and telecare, 2020-04, Vol.26 (3), p.180-185

2020

Volltextzugriff (PDF)

Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review

Transplant infectious disease, 2024-06, Vol.26 (3), p.e14301-n/a

2024

Volltextzugriff (PDF)

A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)

Clinical infectious diseases, 2023-10, Vol.77 (8), p.1102-1110

2023

Volltextzugriff (PDF)

Outcomes of community‐based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation

Internal medicine journal, 2021-11, Vol.51 (11), p.1927-1934

2021

Volltextzugriff (PDF)

Very late‐onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation

Transplant infectious disease, 2021-02, Vol.23 (1), p.e13441-n/a

2021

Volltextzugriff (PDF)

21. Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S14-S15

2021

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(66)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy

Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency

Predictors and incidence of sexually transmitted Hepatitis C virus infection in HIV positive men who have sex with men

Beyond injecting drug use: investigation of a Victorian cluster of hepatitis C among HIV-infected men who have sex with men

Guarding the sleeping giant: hepatitis B screening and management in patients with hematological malignancy

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

Current treatment of HIV/hepatitis B virus coinfection

Reduced Hepatitis B Virus (HBV)-Specific CD4+ T-Cell Responses in Human Immunodeficiency Virus Type 1-HBV-Coinfected Individuals Receiving HBV-Active Antiretroviral Therapy

Non-cirrhotic portal hypertension in HIV mono-infected patients

Why do we not yet have combination chemotherapy for chronic hepatitis B?

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what’s in the pipeline?

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Management of healthcare workers after occupational exposure to hepatitis C virus

An audit of obstetricians’ management of women potentially infected with blood‐borne viruses

Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review

A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)

Outcomes of community‐based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation

Very late‐onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation

21. Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results

Suchergebnisse filtern